Modern medicine is advancing at faster speeds than ever before, yet the world still sees the healthcare experience as difficult and dated. The Real Chemistry Podcast shares interviews with industry leaders who are innovating in healthcare. Join Real Chemistry’s Chief Marketing Officer Aaron Strout as he explores how AI and ideas can come together to transform healthcare into what it should be.
…
continue reading
1
Partnering to Unlock Hope for the Future of Cancer Care: Live from SXSW 2024
41:54
41:54
Na później
Na później
Listy
Polub
Polubione
41:54
While there is undeniable hope for the future of cancer care, systemic barriers still impact access for many patients – particularly those in underserved communities. This session, originally recorded in front of a live audience at SXSW 2024, examines how increasing collaboration and partnerships among organizations that touch all aspects of the ca…
…
continue reading
1
Advancing Medical Communications by Combining Data, Creativity and Human Expertise: Suzanne Jacobs, Real Chemistry & Trina Stonner, Avant Healthcare
29:31
29:31
Na później
Na później
Listy
Polub
Polubione
29:31
In this episode, Suzanne Jacobs, Group President of Medical at Real Chemistry, and Trina Stonner, President of Avant Healthcare, discuss Real Chemistry’s newly announced acquisition of Avant Healthcare, how the two companies came together and have similar ethos of supporting physicians in advancing patient care, and how the future of medical commun…
…
continue reading
1
Caregiving and Cancer Prevention: Dr. Karen Knudsen, The American Cancer Society & Jim Weiss, Real Chemistry
37:19
37:19
Na później
Na później
Listy
Polub
Polubione
37:19
It's time to talk about cancer prevention and early detection. Join us as we explore the importance of early detection and prevention in the fight against cancer with Dr. Karen Knudsen, CEO of the American Cancer Society, and Jim Weiss, Founder and Chairman at Real Chemistry. Tune in to learn about the role of the American Cancer Society in researc…
…
continue reading
1
Using Generative AI to Bring New Perspectives to Medical Problem Solving: Peter Lee, Microsoft & Brandon Pletsch, Real Chemistry
45:08
45:08
Na później
Na później
Listy
Polub
Polubione
45:08
Listen to our latest podcast with Peter Lee, Corporate Vice President, Microsoft Research & Incubations, and Brandon Pletsch, Practice Leader of Scientific Visualization at Real Chemistry, to learn about the applications and implications of generative AI, specifically GPT-4, in healthcare and other fields. They explore public perceptions of AI, its…
…
continue reading
1
Enhancing Healthcare Consistency Through AI: Ajit Singh, Artiman Ventures
40:58
40:58
Na później
Na później
Listy
Polub
Polubione
40:58
In this episode, Ajit Singh, PhD, Managing Director and General Partner at Artiman Ventures, shares his insights on various aspects of healthcare, his approach to leadership and decision-making and his thoughts on the future of healthcare. From AI to oncology to neuro technology, Ajit covers it all.Autor: Real Chemistry
…
continue reading
1
Reshaping the Medical Communications World through AI: Jason Gardner, SVP, Head of Medical, Real Chemistry
20:57
20:57
Na później
Na później
Listy
Polub
Polubione
20:57
Learn more about the inspiring journey of Jason Gardner, Head of Medical at Real Chemistry, and his views on AI and DE&I in healthcare. From his father's struggle with multiple sclerosis to his strategic approach to medical communications, Jason shares his unique perspectives on how diverse thinking and experiences can bring value to the healthcare…
…
continue reading
1
Requiring Transparency and Value-Based Care in the Pharmaceutical Industry: John O'Brien, National Pharmaceutical Council
47:55
47:55
Na później
Na później
Listy
Polub
Polubione
47:55
In this episode, National Pharmaceutical Council (NPC) President and CEO John O'Brien, PharmD, MPH, joins Real Chemistry’s Founder and Chairman, Jim Weiss, to discuss the pharmaceutical industry, the value assessment of medicines, the role of government in drug pricing and the importance of research in healthcare policy. Tune in to get the latest i…
…
continue reading
1
Tackling Health Disinformation in the AI and Digital Age: Dr. Geeta Nayyar, Author, Dead Wrong
27:08
27:08
Na później
Na później
Listy
Polub
Polubione
27:08
Misinformation in the digital age is a complex problem, but it can be addressed. In this episode, Dr. Geeta Nayyar, former Chief Medical Officer at Salesforce and AT&T, discusses her book, Dead Wrong, and the role of artificial intelligence in healthcare. Tune in to learn more about the importance of trust in the healthcare industry, the role of li…
…
continue reading
1
Valuing Empathy to Ensure Patient-Centered Healthcare Strategies: Javeria Shahab, 21GRAMS, a part of Real Chemistry
31:32
31:32
Na później
Na później
Listy
Polub
Polubione
31:32
In this episode, Javeria Shahab, President of Medical Education at 21GRAMS, a part of Real Chemistry, discusses the challenges and changes in the medical education industry, building effective teams and the importance of empathy in healthcare communications. Get an insider's look into the industry and hear Javeria's advice for those looking to brea…
…
continue reading
1
Informing Public Health Decisions with Data and Science: Sue Desmond-Hellmann, M.D., Council of Advisors on Science and Technology
55:09
55:09
Na później
Na później
Listy
Polub
Polubione
55:09
In this episode, Dr. Sue Desmond-Hellmann, Member of President Biden’s Council of Advisors on Science and Technology and former CEO of the Bill & Melinda Gates Foundation, Mike Huckman, Global Practice Leader of Executive Communications at Real Chemistry, and Jim Weiss, Founder and Chairman at Real Chemistry, discuss the importance of vaccination, …
…
continue reading
1
Pioneering Public-Private Partnerships to Tackle Complex Health Issues: Dr. Julie Gerberding, FNIH, Dr. Jay Bradner, FNIH & Jim Weiss, Real Chemistry
55:09
55:09
Na później
Na później
Listy
Polub
Polubione
55:09
In this episode, Dr. Julie Gerberding, President and CEO of the Foundation for the National Institutes of Health (FNIH), Dr. Jay Bradner, FNIH board member and former President of the Novartis Institutes for Biomedical Research, and Jim Weiss, Founder and Chairman at Real Chemistry and FNIH board member, discuss the power of collaboration, how trus…
…
continue reading
1
Analyzing the Impact of Data and Technology on Healthcare Commercialization: Mark Martin, Houlihan Lokey & Jim Weiss, Real Chemistry
37:46
37:46
Na później
Na później
Listy
Polub
Polubione
37:46
In this episode, Mark Martin, Managing Director at Houlihan Lokey, and Jim Weiss, Founder and Chairman at Real Chemistry, explore the healthcare marketing and commercialization industry, including the impact of data and technology, trends in acquisitions and deals, and the importance of organic growth and innovation.…
…
continue reading
1
Developing Innovative Digital Medicine Solutions that Address Real Pain Points: Jennifer Goldsack, Digital Medicine Society
40:16
40:16
Na później
Na później
Listy
Polub
Polubione
40:16
Digital medicine is essential for improving healthcare and addressing issues related to access and equity. In the latest episode, learn about the importance of digital medicine, the challenges and opportunities in the industry and the importance of an integrated evidence plan. Plus, CEO and Co-Founder of the Digital Medicine Society (DiMe), Jennife…
…
continue reading
1
Addressing Liver Health through Collaboration and Innovation: Donna Cryer, Global Liver Institute
32:37
32:37
Na później
Na później
Listy
Polub
Polubione
32:37
Did you know that there are more than 100 types of liver diseases that affect 1.5 billion people worldwide? Join us as we explore the importance of collaboration and innovation in addressing liver health issues, the role of digital health and equity, and the future of liver health with Donna Cryer, J.D., Founder, President and CEO of the Global Liv…
…
continue reading
1
Exploring Space as the Next Frontier for Biopharma R&D: Maureen Haverty, Seraphim Space/Generation Space
29:53
29:53
Na później
Na później
Listy
Polub
Polubione
29:53
Space exploration and research are rapidly advancing, and life sciences is a key component of this progress. Learn more about the opportunities and developments in space R&D and manufacturing, particularly in the life sciences sector, from Maureen Haverty, VP of Investment at Seraphim Space/Generation Space.…
…
continue reading
1
Transforming How Patients Manage Chronic Conditions: Waqaas Al-Siddiq, Biotricity
25:45
25:45
Na później
Na później
Listy
Polub
Polubione
25:45
In this episode with Biotricity CEO and Founder Waqaas Al-Siddiq, PhD, discover how AI is transforming healthcare and how Biotricity's Bioheart device is helping to manage and prevent cardiac conditions.Autor: Real Chemistry
…
continue reading
1
Using Effective Communication to Build Strong Bridges: Sally Susman, Pfizer & Jim Weiss, Real Chemistry
49:11
49:11
Na później
Na później
Listy
Polub
Polubione
49:11
Communication is a critical skill for leaders and company culture. In this episode, Real Chemistry Founder and Chairman Jim Weiss is joined by Sally Susman, Chief Corporate Affairs Officer of Pfizer and author of "Breaking Through," who shares her insights on the importance of communication in leadership, building corporate and product brands, and …
…
continue reading
1
Delivering Personalized Care for Chronic Health Conditions: Live from SXSW 2023 with Lee Shapiro
27:31
27:31
Na później
Na później
Listy
Polub
Polubione
27:31
Recorded live from SXSW 2023, 7wire Ventures Co-Founder & Managing Partner Lee Shapiro explores how technology, data and collaboration can be used to make healthcare more personalized, efficient and cost-effective, ultimately leading to improved health outcomes.Autor: Real Chemistry
…
continue reading
1
Generative AI: Oh God What Now?: Live from SXSW 2023
33:49
33:49
Na później
Na później
Listy
Polub
Polubione
33:49
With tools like ChatGPT and DALL-E dominating news cycles, many people – especially those working in creative jobs – are wondering if they will soon be replaced by the technology known as generative AI. During this session, originally recorded in front of a live audience at SXSW 2023, Sameer Grover, CNS Sr. Specialty Division Manager at AbbVie, and…
…
continue reading
1
Becoming a Change Agent through Impactful Disruption: Live from SXSW 2023 with GSK’s Alison Woo
26:11
26:11
Na później
Na później
Listy
Polub
Polubione
26:11
Recorded live from SXSW 2023, Alison Woo, Head of Strategy, Planning and Paid Campaigns, Communications & Government Affairs at GSK, shares what a day in her life looks like, what she gathered at SXSW this year and what it means to be disruptive at a company without being too disruptive.Autor: Real Chemistry
…
continue reading
1
A Day in the Life of a Biopharmaceutical Leader: Live from SXSW 2023
42:12
42:12
Na później
Na później
Listy
Polub
Polubione
42:12
This presentation, originally recorded in front of a live audience at SXSW 2023, showcases key stories and perspectives on what a day in the life of a leader at Bristol-Myers Squibb looks like. From their experiences and challenges to how their focus on patients drives them to continue to strive in their role during these truly complicated times. P…
…
continue reading
1
Innovating Data Approaches for Clinical Trial Recruitment: Live from SXSW 2023
47:15
47:15
Na później
Na później
Listy
Polub
Polubione
47:15
This panel, originally recorded in front of a live audience at SXSW 2023, discusses innovative data sources for clinical trial recruitment and how to maximize their effectiveness. The panel explores a range of innovative data sources, such as online platforms, real world data and social networks, and how they can be used to find the right candidate…
…
continue reading
1
Understanding Trends to Shape our Future Normal: Rohit Bhargava, Founder & Chief Trend Curator, Non-Obvious Company
28:52
28:52
Na później
Na później
Listy
Polub
Polubione
28:52
Recorded live from SXSW 2023, Founder & Chief Trend Curator of the Non-Obvious Company Rohit Bhargava joins us to discuss why he continues to come back to SXSW, how the event has evolved and his new book co-authored with Henry Coutinho-Mason, The Future Normal, which leans into healthcare trends.Autor: Real Chemistry
…
continue reading
1
Changing the Relationship of Underserved Populations with Clinical Trials: Dr. Keolu Fox, Co-Founder, Native BioData Consortium & Assistant Professor, University of California, San Diego
34:24
34:24
Na później
Na później
Listy
Polub
Polubione
34:24
Indigenous futurist and technologist Dr. Keolu Fox joins us this week to discuss how increased diversity in clinical trials can transform healthcare for underserved populations and for the overall healthcare system.Autor: Real Chemistry
…
continue reading
1
Building a Community of Caregivers: Andrew Parker, CEO & Founder, Papa
33:24
33:24
Na później
Na później
Listy
Polub
Polubione
33:24
This week, CEO & Founder of Papa Andrew Parker joins the podcast and discusses how his company is empowering a new kind of healthcare built on human connection. Papa, a platform that connects older adults with Pals who provide companionship and assistance, seeks to address the caregiving shortage and support the US healthcare system’s Triple Aim.…
…
continue reading
1
Addressing a New Wave of Healthcare Challenges: Annalisa Jenkins, Compass Pathways & Jim Weiss, Real Chemistry
38:35
38:35
Na później
Na później
Listy
Polub
Polubione
38:35
Annalisa Jenkins, MBBS, Non Executive Director at Compass Pathways & Jim Weiss, Founder and Chairman at Real Chemistry, join the podcast this week to discuss women in life sciences leadership roles, novel approaches to disease areas such as infectious diseases and cancer, and using AI for a more effective healthcare system.…
…
continue reading
1
Breaking Down Healthcare Industry Barriers: Chas Bountra, PhD, Pro Vice-Chancellor for Innovation & Professor for Translational Medicine, University of Oxford & Jim Weiss, Founder & CEO, Real Chemistry ...
36:34
36:34
Na później
Na później
Listy
Polub
Polubione
36:34
Chas Bountra, PhD, Pro Vice-Chancellor for Innovation & Professor for Translational Medicine at the University of Oxford, and Jim Weiss, Founder & CEO of Real Chemistry, join this week’s episode to discuss accelerating healthcare through novel ideas and the importance of collaborating across organizations, industries and countries.…
…
continue reading
1
Democratizing Access to Healthcare: Pranam Ben, Founder & CEO, The Garage
28:23
28:23
Na później
Na później
Listy
Polub
Polubione
28:23
Founder and CEO of The Garage, Pranam Ben, joins us to discuss the future of value-based care and The Garage’s approach of using technology and data to solve for equity and access issues facing the healthcare industry. Read The Garage’s blog post, Tiny Tasty Morsels, to learn about their Quintuple Aim approach to change healthcare for good.…
…
continue reading
1
Building the Future of HEOR: Christopher Boone, PhD, VP & Global Head of HEOR, AbbVie
29:23
29:23
Na później
Na później
Listy
Polub
Polubione
29:23
In this week’s episode, Christopher Boone, PhD, VP & Global Head of Health Economic Outcomes and Research (HEOR) at AbbVie, discusses the changing landscape of HEOR, the importance of leadership, collaboration and innovation in the pharmaceutical industry, and the story behind his Twitter handle, DataHippie.…
…
continue reading
1
Improving Patient Care through Better Data Interoperability: Frank Harvey, CEO, Surescripts
18:18
18:18
Na później
Na później
Listy
Polub
Polubione
18:18
In this week’s episode, Surescripts CEO Frank Harvey discusses how Surescripts is improving healthcare data interoperability and better empowering pharmacists to provide primary care to patients.Autor: Real Chemistry
…
continue reading
1
Harnessing the Human Approach: Harpreet Sood, MD, VP, Primary Care & Clinical Partnerships, Huma
25:48
25:48
Na później
Na później
Listy
Polub
Polubione
25:48
Huma VP of Primary Care & Clinical Partnerships Harpreet Sood, MD discusses shifts in the digital health market and how Huma differentiates itself through a focus on patient centricity and collaboration across healthcare systems and teams.Autor: Real Chemistry
…
continue reading
1
Simplifying Medicine with Technology: Matt Titus, VP & Chief Commercial Officer, epocrates
21:28
21:28
Na później
Na później
Listy
Polub
Polubione
21:28
Data and technology should make physicians’ lives simpler, not more complicated. Matt Titus, VP & Chief Commercial Officer, epocrates, shares how his team is making an impact.Autor: Real Chemistry
…
continue reading
1
Advocating for Patients: Elle Cole, Founder of Cleverly Changing, Patient Advocate & Author
16:01
16:01
Na później
Na później
Listy
Polub
Polubione
16:01
Working toward creating better patient outcomes and experiences is something we have in common with Elle Cole, Founder of Cleverly Changing, Patient Advocate & Author.Autor: Real Chemistry
…
continue reading
1
Assessing the State of COVID-19: Monica Gandhi MD, MPH, Professor of Medicine, UCSF
32:25
32:25
Na później
Na później
Listy
Polub
Polubione
32:25
The doctor will see you now! Monica Gandhi, MD, MPH, Professor of Medicine, UCSF, is back on the show, and she’s talking about all things COVID-19, flu, and vaccines.Autor: Real Chemistry
…
continue reading
1
Investing in Marketing & Analytics: Mark Stouse, Chairman & CEO, Proof
27:22
27:22
Na później
Na później
Listy
Polub
Polubione
27:22
Investing in marketing and analytics is critical to navigating your organization successfully. Mark Stouse, Chairman & CEO of Proof, and Jim Weiss, Founder & Chairman of Real Chemistry, join the show to discuss this and the current state of marketing.Autor: Real Chemistry
…
continue reading
1
Advancing Health Equity: Mary Stutts, Chief Global Health Equity & Inclusion Officer, Real Chemistry
31:15
31:15
Na później
Na później
Listy
Polub
Polubione
31:15
Mary Stutts, Real Chemistry’s Chief Global Health Equity and Inclusion Officer, is back on the show to discuss why investing in health equity makes our industry more inclusive, digitally driven, equitable, and, ultimately, more profitable.Autor: Real Chemistry
…
continue reading
1
Addressing Aging: Juliette Han, PhD, COO & CFO, Cambrian BioPharma
34:15
34:15
Na później
Na później
Listy
Polub
Polubione
34:15
Addressing aging is a challenge that our client Juliette Han, PhD, COO and CFO of Cambrian BioPharma, welcomes because it's universal. Learn how Dr. Han and her team are aiming to increase "healthspan."Autor: Real Chemistry
…
continue reading
1
Accelerating the American Cancer Society’s Mission: Alice Lin Pomponio, Managing Director, BrightEdge Fund
38:34
38:34
Na później
Na później
Listy
Polub
Polubione
38:34
This week’s guest is dedicated to accelerating the American Cancer Society’s (ACS) mission. Alice Lin Pomponio joins the show to discuss how the BrightEdge Fund accelerates the ACS’ goal to reduce cancer mortality, end pain and suffering, and advance health equity. Plus, she shares her love of a hit Broadway musical.…
…
continue reading
1
Accelerating Diversity & Inclusion: Marcus Sawyerr, Founder & CEO, EQ Community
34:23
34:23
Na później
Na później
Listy
Polub
Polubione
34:23
Marcus Sawyerr, Founder & CEO of EQ Community, rejoins the show, but a lot has changed since the last time we spoke, like his mission to accelerate diversity and inclusion. And some things have remained the same, like his appreciation of JAY-Z.Autor: Real Chemistry
…
continue reading
1
Revolutionizing Neurodiagnostics and Brain Therapeutics: Mary Lou Jepsen, Ph.D., CEO & Founder, Openwater
39:43
39:43
Na później
Na później
Listy
Polub
Polubione
39:43
Inventor, trailblazer and one of the 100 most influential people in the world, according to TIME Magazine, Mary Lou Jepsen, Ph.D., joins the show. She shares how her company, Openwater, is changing the game in neurotherapeutics and why she'd want a record player on a deserted island. Learn more about this incredible work via Dr. Jepsen’s Life Itsel…
…
continue reading
1
Keeping the Biomedical Innovation System Humming: Peter Kolchinsky, Ph.D., Biotech Investor, Scientist & Author
22:58
22:58
Na później
Na później
Listy
Polub
Polubione
22:58
Biotech investor, scientist and author Peter Kolchinsky, Ph.D. joins the show with our Founder and Chairman, Jim Weiss, to discuss what the passing of the Prescription Drug Pricing Reform bill would mean for our industry.Autor: Real Chemistry
…
continue reading
1
Making Health Care Approachable: Dr. Geeta Nayyar, Chief Medical Officer, Salesforce
18:16
18:16
Na później
Na później
Listy
Polub
Polubione
18:16
Making health information more approachable, simple and easy to understand will improve health literacy and ultimately improve patient outcomes. Dr. Geeta Nayyar, Chief Medical Officer of Salesforce, joins the show to discuss health misinformation and her takeaways from the Life Itself conference, plus she shares her love of U2.…
…
continue reading
1
Honoring and Celebrating Caregivers: Alexandra Drane, CEO & Co-Founder, ARCHANGELS
16:23
16:23
Na później
Na później
Listy
Polub
Polubione
16:23
Unpaid caregiving can often feel like a thankless job. This week’s guest, Alexandra Drane, is here to change that with her organization ARCHANGELS.Autor: Real Chemistry
…
continue reading
1
Fighting Hate for Good: Jonathan Greenblatt, CEO & National Director, Anti-Defamation League
39:33
39:33
Na później
Na później
Listy
Polub
Polubione
39:33
Securing justice and fair treatment for all is at the core of what Anti-Defamation League’s work. Jonathan Greenblatt, CEO & National Director of the ADL, discusses how we can fight all forms of hate for good with Jim Weiss, Real Chemistry Founder & Chairman.Autor: Real Chemistry
…
continue reading
1
Putting Patients, Caregivers, and Community at the Center: Sally Schaeffer, VP of Community Engagement Strategy, Real Chemistry
36:28
36:28
Na później
Na później
Listy
Polub
Polubione
36:28
Patients, caregivers, and their communities are at the center of our work, and nobody is a better advocate for these individuals than Sally Schaeffer our, VP of Community Engagement Strategy. In this episode, Sally tells her heartbreaking yet inspiring story of advocating for Sudden Unexpected Death in Epilepsy (SUDEP), learning how to be there for…
…
continue reading
1
Electing Scientific and Health Care Leaders during Turbulent Times: Shaughnessy Naughton, Founder/President of 314 Action
32:31
32:31
Na później
Na później
Listy
Polub
Polubione
32:31
Our guest this week is an expert in harnessing the voices of trusted scientific sources to spread vital health information. Action 314’s Founder and President, Shaughnessy Naughton, sits down to discuss why electing scientific and health care experts to our government re-builds trust during turbulent times.…
…
continue reading
1
Evolving the ASCO Experience: Real Chemistry Experts Dissect Trends Driving the Future of Medical Congresses
27:39
27:39
Na później
Na później
Listy
Polub
Polubione
27:39
The cancer landscape is evolving at record speed – and so too are the expectations and experiences of attendees at the annual ASCO (American Society for Clinical Oncology) meeting, held annually in Chicago from June 3-7. Join Real Chemistry’s Jennifer Paganelli, Ujwal Pyati, and Brandon Pletsch, some our medical, media and creative experts, as they…
…
continue reading
1
Understanding Current Risks, Treatments, and Prevention of COVID-19: Dr. Monica Gandhi (UCSF/ San Francisco General Hospital) and Jim Weiss (Real Chemistry Founder and Chairman)
25:49
25:49
Na później
Na później
Listy
Polub
Polubione
25:49
We’re back with Dr. Monica Gandhi and our own Jim Weiss! We’ve loved checking in with these two about the current state of COVID-19, and this time, they delivered an uplifting assessment and a ton of recent data and studies to back it up.Autor: Real Chemistry
…
continue reading
1
Disrupting the Social Media World: Talking Elon Musk’s Twitter Deal with Chuck Hemann, Anke Knospe, and Jurgen Castro
38:40
38:40
Na później
Na później
Listy
Polub
Polubione
38:40
Last week, Elon Musk bought Twitter, plunging the platform and our role in it into an uncertain future. At the highest level, what could this mean for health care communicators, practitioners, and patients looking for information? We sat down with our own social media experts, Chuck Hemann, Anke Knospe, and Jurgen Castro to hear their expert opinio…
…
continue reading
1
Liberating Menstruators from Painful & Messy Periods: Lauren Wang, Founder & CEO, The Flex Company
34:35
34:35
Na później
Na później
Listy
Polub
Polubione
34:35
We’re diving into a new topic on the podcast: menstrual health. Lauren Wang, Founder and CEO of The Flex Company, discusses how her company innovates in health care and makes periods a more normal and empathetic topic in everyday life. Plus, she shares her expert advice for female entrepreneurs pitching to a room full of men.…
…
continue reading